Giovanni Guidotti

No ORCID on file · 1 paper in corpus
2024
·doi:10.21203/rs.3.rs-5676736/v1

Abstract Introduction The global HIV epidemic remains a public health challenge. Dolutegravir (DTG) has become a cornerstone of antiretroviral therapy (ART) regimens due to its efficacy and tolerability. However, the emergence of DTG resis…